[go: up one dir, main page]

Valliere-Douglass et al., 2008 - Google Patents

Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass …

Valliere-Douglass et al., 2008

Document ID
4511227698727678622
Author
Valliere-Douglass J
Jones L
Shpektor D
Kodama P
Wallace A
Balland A
Bailey R
Zhang Y
Publication year
Publication venue
Analytical chemistry

External Links

Snippet

Hydrophobic interaction chromatography (HIC) was used to separate populations of recombinant IgG2 antibody that were created as a result of prolonged incubation at 40° C. Antibody was separated by HIC into three major and seven minor fractions. All but one …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes

Similar Documents

Publication Publication Date Title
Valliere-Douglass et al. Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry
Füssl et al. Comparative elucidation of cetuximab heterogeneity on the intact protein level by cation exchange chromatography and capillary electrophoresis coupled to mass spectrometry
Yan et al. Ultrasensitive characterization of charge heterogeneity of therapeutic monoclonal antibodies using strong cation exchange chromatography coupled to native mass spectrometry
Huang et al. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS
D’Atri et al. Hydrophilic interaction chromatography hyphenated with mass spectrometry: a powerful analytical tool for the comparison of originator and biosimilar therapeutic monoclonal antibodies at the middle-up level of analysis
Sjögren et al. Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis
Gstöttner et al. Fast and automated characterization of antibody variants with 4D HPLC/MS
Zhang et al. Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody
Neill et al. Characterization of recombinant monoclonal antibody charge variants using OFFGEL fractionation, weak anion exchange chromatography, and mass spectrometry
Biacchi et al. Glycoform separation and characterization of cetuximab variants by middle-up off-line capillary zone electrophoresis-UV/electrospray ionization-MS
Cai et al. C‐terminal lysine processing of human immunoglobulin G2 heavy chain in vivo
Beck et al. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry
Dai et al. A middle-up approach with online capillary isoelectric focusing/mass spectrometry for in-depth characterization of cetuximab charge heterogeneity
Paul et al. Structure and function of purified monoclonal antibody dimers induced by different stress conditions
Camperi et al. Development of a 3D-LC/MS workflow for fast, automated, and effective characterization of glycosylation patterns of biotherapeutic products
Camperi et al. Fast and automated characterization of monoclonal antibody minor variants from cell cultures by combined protein-A and multidimensional LC/MS methodologies
Du et al. Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis
Hanisch Top-down sequencing of O-glycoproteins by in-source decay matrix-assisted laser desorption ionization mass spectrometry for glycosylation site analysis
Ye et al. Direct approach for qualitative and quantitative characterization of glycoproteins using tandem mass tags and an LTQ Orbitrap XL electron transfer dissociation hybrid mass spectrometer
Gaza-Bulseco et al. Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody
Toyama et al. Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring
Dada et al. Characterization of acidic and basic variants of IgG1 therapeutic monoclonal antibodies based on non‐denaturing IEF fractionation
Liu et al. Coupling anion exchange chromatography with native mass spectrometry for charge heterogeneity characterization of monoclonal antibodies
Xiao et al. 18O labeling method for identification and quantification of succinimide in proteins
Regl et al. A generic HPLC method for absolute quantification of oxidation in monoclonal antibodies and Fc-fusion proteins using UV and MS detection